Clinical trial

Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)

NCT03421912

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Cicaplast Balm B5 Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Dexeryl Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-02-16

PhaseNA

Conditions

Head and Neck Squamous Cell Carcinomaverified · MONDO: head and neck squamous cell carcinoma

Colorectal Cancerverified · MONDO: colorectal cancer

Non Small Cell Lung Cancercandidate · MONDO: non-small cell lung carcinoma

Epidermal Growth Factor Receptor Inhibitorunresolved

Interventions

Cicaplast Balm B5OTHER

DexerylOTHER

Sponsors & collaborators

Centre Leon Berardlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03421912 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.